Answers are grounded in this paper and cite their sources.
Selenium administration significantly improved quality of life, reduced ocular involvement, and slowed progression of the disease in patients with mild Graves' orbitopathy. (Funded by the University of Pisa and the Italian Ministry for Education, University and Research; EUGOGO Netherlands Trial Register number, NTR524.).
No takes yet. Share an insight, caveat, or question.
Marcocci et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: